105 related articles for article (PubMed ID: 32914167)
1. Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.
Khan AA; Khan Z
Brief Bioinform; 2021 Mar; 22(2):1206-1214. PubMed ID: 32914167
[TBL] [Abstract][Full Text] [Related]
2. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.
Yamamoto M; Matsuyama S; Li X; Takeda M; Kawaguchi Y; Inoue JI; Matsuda Z
Antimicrob Agents Chemother; 2016 Nov; 60(11):6532-6539. PubMed ID: 27550352
[TBL] [Abstract][Full Text] [Related]
3. Ca
Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
[TBL] [Abstract][Full Text] [Related]
4. The current landscape of coronavirus-host protein-protein interactions.
Perrin-Cocon L; Diaz O; Jacquemin C; Barthel V; Ogire E; Ramière C; André P; Lotteau V; Vidalain PO
J Transl Med; 2020 Aug; 18(1):319. PubMed ID: 32811513
[TBL] [Abstract][Full Text] [Related]
5. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Matsuyama S; Nao N; Shirato K; Kawase M; Saito S; Takayama I; Nagata N; Sekizuka T; Katoh H; Kato F; Sakata M; Tahara M; Kutsuna S; Ohmagari N; Kuroda M; Suzuki T; Kageyama T; Takeda M
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7001-7003. PubMed ID: 32165541
[TBL] [Abstract][Full Text] [Related]
6. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
7. How lessons learned from the 2015 Middle East respiratory syndrome outbreak affected the response to coronavirus disease 2019 in the Republic of Korea.
Yang TU; Noh JY; Song JY; Cheong HJ; Kim WJ
Korean J Intern Med; 2021 Mar; 36(2):271-285. PubMed ID: 32872738
[TBL] [Abstract][Full Text] [Related]
8. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
[TBL] [Abstract][Full Text] [Related]
10. Alignment of virus-host protein-protein interaction networks by integer linear programming: SARS-CoV-2.
Llabrés M; Valiente G
PLoS One; 2020; 15(12):e0236304. PubMed ID: 33284827
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-specific virulence factors in COVID-19.
Kumar A; Prasoon P; Kumari C; Pareek V; Faiq MA; Narayan RK; Kulandhasamy M; Kant K
J Med Virol; 2021 Mar; 93(3):1343-1350. PubMed ID: 33085084
[TBL] [Abstract][Full Text] [Related]
12. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
[TBL] [Abstract][Full Text] [Related]
14. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
[TBL] [Abstract][Full Text] [Related]
15. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Drak Alsibai K
Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
[TBL] [Abstract][Full Text] [Related]
17. Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation.
Thornbrough JM; Jha BK; Yount B; Goldstein SA; Li Y; Elliott R; Sims AC; Baric RS; Silverman RH; Weiss SR
mBio; 2016 Mar; 7(2):e00258. PubMed ID: 27025250
[TBL] [Abstract][Full Text] [Related]
18. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
19. Targeting Proteases for Treating COVID-19.
Luan B; Huynh T; Cheng X; Lan G; Wang HR
J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793
[TBL] [Abstract][Full Text] [Related]
20. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
